Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation.
Ever since the discovery of insulin a century ago, relentless attempts have been made to develop insulins that closely mimic the timeaction- profile of human physiologic insulin. The early basal insulins like neutral protamine Hagedorn (NPH), were interme..... Read More